Therefore, it will be interesting to see how the two forms of CDC42 affect the expression and/or activation levels of mTOR and the EGFR in adult brains and whether the deregulation of these CDC42 splice variants is involved in the pathogenesis responsible for neurodegenerative diseases. This evidence concerns the gene CDC42 and neurodegenerative disease.